[144] AMBARELLA INC SEC Filing
Rhea-AI Filing Summary
Ambarella, Inc. filed a Form 144 notifying a proposed sale of 2,664 common shares with an aggregate market value of $227,444.59. The shares are scheduled for sale approximately on 10/06/2025 on NASDAQ. The filing lists six restricted‑stock grants from the issuer dated between 12/15/2020 and 09/15/2025 that together total the 2,664 shares to be sold, and shows no securities sold by the reporting person in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
Small insider sale of restricted stock, filed under Rule 144.
The filing documents a proposed sale of $227,444.59 worth of common stock arising from six restricted stock grants spanning 2020–2025
The sale is listed for 10/06/2025 on NASDAQ; the filing also confirms no sales in the past three months. Monitor public disclosures or subsequent Form 4 filings for actual sale execution or any change in the stated plan within days following the listed date.
Form 144 documents Rule 144 notice and the seller's statutory attestations.
The submission provides required acquisition details including dates and that the securities were granted as restricted stock by the issuer, and contains the statutory representation about material nonpublic information.
Watch for a related Form 4 after the sale date showing execution details and confirm that the transaction follows the trading plan/Rule 10b5‑1 timing if one exists.